
A strain of bird flu that has long been regarded as relatively harmless may not be as benign as once thought. Researchers tracking the evolution of the H9N2 avian influenza virus say it is showing increasing signs of adapting to infect humans — a development that could, if unchecked, pose a serious pandemic risk. Experts are calling for intensified global monitoring of this underestimated threat before it becomes the next major public health crisis.
For years, the world’s attention has been fixed on the highly pathogenic H5N1 strain, which has spread across multiple continents and caused devastating outbreaks in both humans and animals. Since 2020, H5N1 has killed at least 21 people and has alarmingly begun circulating among dairy cows in North America. In comparison, H9N2 has received far less scrutiny — even though it is the second most common avian influenza subtype known to infect humans.
Kelvin To, a clinical microbiologist at the University of Hong Kong, explained at the Pandemic Research Alliance International Symposium in Melbourne on October 27 that H9N2 has infected at least 173 people since it was first detected in humans in 1998, most of them in China. “The numbers may appear small,” To said, “but they likely represent just the tip of the iceberg.”
Other experts agree. Michelle Wille, a bird flu researcher at the Peter Doherty Institute for Infection and Immunity in Melbourne, noted that mild or asymptomatic cases of H9N2 may be going undetected. Because H9N2 infections typically do not lead to severe illness or hospitalization, they can easily slip under the radar — especially when diagnostic testing focuses primarily on H5N1. “The lack of widespread testing means we may be missing a much larger pool of infections,” Wille said.
A Virus in Evolution
While there is currently no evidence that H9N2 can spread efficiently from person to person — a critical requirement for triggering a pandemic — scientists have uncovered worrisome signs of viral adaptation. To and his colleagues have traced a series of genetic changes in the virus that began around 2015, suggesting that H9N2 has become progressively more capable of infecting human cells.
In laboratory experiments, a 2024 sample of the virus was shown to infect far more human cells than a 1999 version. Moreover, the newer strain exhibited a stronger ability to bind to receptors on human cells — the molecular “locks” that viruses must open to gain entry. According to the study, published earlier this month in Emerging Microbes & Infections, these mutations indicate that H9N2 is becoming increasingly suited to infect humans.
For the virus to become truly pandemic-capable, however, several more evolutionary steps would still be required. Wille explained that H9N2 would need to shift its preference from receptors typically found in birds to those found in the human respiratory tract. It would also need to adapt to human body temperatures and pH levels, both of which differ from those of birds.
The Case for Heightened Surveillance
Despite these remaining barriers, experts say the warning signs are clear. “This is not a virus we can afford to ignore,” said Wille. “Even if it is currently classified as low pathogenic, its potential to evolve makes it a concern for global health.”
One challenge is that many countries are not required to report infections involving low-pathogenic avian influenza strains like H9N2. This lack of mandatory reporting creates significant blind spots in global disease monitoring efforts. As a result, researchers may be missing important signals that the virus is spreading or changing in dangerous ways.
To emphasizes that enhanced surveillance of mammals in close proximity to wild birds and poultry is also critical. Monitoring animals such as pigs, cows, and other domesticated species could provide early warnings about the virus’s adaptability to mammalian hosts. “If H9N2 is starting to infect mammals more easily, that would be a strong indicator that it’s gaining the traits needed to infect humans,” he explained.
The Threat of Genetic Mixing
Another pressing concern is the potential for viral reassortment — a process where genetic material from different influenza viruses mixes within a single infected host. When animals or humans are infected with multiple flu strains at once, segments of their viral genomes can be swapped, creating entirely new variants. This genetic “mix and match” process has historically played a major role in the emergence of pandemic strains, including the 2009 H1N1 swine flu.
To and other researchers have already found evidence that fragments of H9N2 genetic material have contributed to the development of other bird flu viruses that later infected humans. This means that even if H9N2 itself does not directly spark a pandemic, it could serve as a genetic donor for future, more dangerous strains.
A Call for Proactive Global Action
Experts say that combating this emerging threat requires a shift in mindset. While H9N2 has not yet caused large-scale human outbreaks, its ongoing evolution demands vigilance. Strengthening global virus surveillance, improving cross-border data sharing, and expanding laboratory capacity in regions with high poultry density are critical steps.
Public awareness and communication are also key. Many people remain unaware that lesser-known flu strains like H9N2 exist at all, let alone that they pose a potential risk. Governments and health organizations must ensure that the global response does not focus solely on the better-known H5N1, but also on its quieter, evolving cousin.
As To warned, “History has shown us that pandemics rarely come from the virus we’re expecting. The time to act is before the next one starts.”






Leave a Reply